throbber
Articles
`
`NAGIN K. PATEL AND LLOYD G. NEWSHAM*
`
`EXPERIMENTS IN PHYSICAL PHARMACY. VI.
`
`FACTORS INFLUENCING ERYTHROCYTE FRAGILITY
`
`AND ISOTONICITY DETERMINATION
`
`Early interest in drug solutions having
`the same osmotic pressure as the body
`fluids was relegated to parenteral solu(cid:173)
`tions, but during the past two decades,
`considerable attention has been given
`to the o:motic pressure of collyriums
`and of nasal preparations.
`Isotonic
`solutions are important because they
`cause no swelling or contraction of the
`tissues with which they come in contact
`and produce no discomfort when in(cid:173)
`stilled into the eye, the nasal tract, the
`blood stream, or other body tissue.
`Hypotonic solutions may be rendered
`isotonic by increasing the drug content
`or by
`the addition of some physi(cid:173)
`ologically inert solute. The proportion
`of the solute to be added may be de(cid:173)
`termined experimentally or calculated
`mathematically.
`Students are familiar with the princi(cid:173)
`ple of the plasmolysis experiment from
`
`their biology courses. Drug solutions
`which come in contact with erythrocytes
`should have the same osmotic pressure
`as that of the cell content in order to
`maintain the cell volume or the normal
`tone of the cell. If red cells are · placed
`in water or in sodium chloride solutiom
`containing less than 0.9 per cent sodium
`chloride, water passes into the blood
`cells with a resultant increase in cell
`volume. If the pressure inside the cells
`is sufficiently great, the cells burst. Vari(cid:173)
`ous factors influence the change in the
`cell volume, and students must be
`familiar with these.
`* At the time this experiment was designed,
`Patel was Associate Professor of Pharma(cid:173)
`ceutics, Faculty of Pharmacy and Phar(cid:173)
`maceutical Sciences, University of Alberta;
`present address: Research Laboratories,
`Frank W. Horner Ltd., Montreal, Quebec,
`Canada. Newsham
`is Associate Professor
`of Physiology, Faculty of Medicine, Univer(cid:173)
`sity of Alberta, Edmonton, Alberta, Canada.
`
`1
`
`Novo Nordisk Ex. 2039, P. 1
`Mylan Institutional v. Novo Nordisk
`IPR2020-00324
`
`

`

`American Journal of Pharmaceutical Education
`
`This paper presents experiments de(cid:173)
`scribing the factors influencing erythro(cid:173)
`cyte fragility, a quantitati,e study on
`osmotic fragility of erythrocytes, and a
`freezing-point-depression (FPD) method
`to determine isotonicity of given solu(cid:173)
`tions.
`
`Theory
`Hemolysis. Only solutes which can(cid:173)
`not pass through a barrier permeable
`to the solvent can exert an osmotic
`pressure ( 1); substances which can pass
`through
`the cell membrane3 cannot,
`therefore, counterbalance
`the osmotic
`pressure exerted by nondiffusible intra(cid:173)
`cellular solutes. Thus, the osmotic con(cid:173)
`centration, measured by a physical
`method based on one of the colligative
`properties, is an expression of the os(cid:173)
`motic pressure only when all the solutes
`present in solution are nondiffusible
`through the cell membrane.
`The membrane of the erythrocyte is
`impermeable, or relatively so, to certain
`solutes. Hence, the volume of water in
`the cell is determined osmotically by the
`composition of the surrounding solu(cid:173)
`tion. The cell can swell or shrink in a
`reversible manner within limits, but at
`a critical volume, the tension on the
`membrane causes it to "rupture" ( or
`become more permeable), and
`the
`cell's contents are released into the sur(cid:173)
`rounding solution.
`When red blood cells ( or other cells)
`are surrounded by aqueous solutions of
`lower osmotic pressure than that inside
`the cell, there is an inward flow of water,
`and the cell volume is increased until the
`osmotic pressures inside and outside the
`cell are equal. If the membrane is too
`fragile to withstand the increased pres(cid:173)
`sure, it will rupture before the osmotic
`pressures on both sides of the membrane
`are equal. This disruption of the red
`cell membrane accompanied by libera(cid:173)
`tion of hemoglobin into the surrounding
`me:lium is termed hemolysis. The op-
`
`2
`
`po3ite process, i.e., the passage of water
`out of the red cell, results in a shrink(cid:173)
`age or crenation of the cell.
`
`By convention, a solution in which
`red blood cells ( or other cells) main(cid:173)
`tain the same volume which they have
`in plasma or tissue fluid is said to be
`isotonic. If the cell volume increases, the
`external solution is hypotonic, and if it
`decreases the solution is hypertonic. Ex(cid:173)
`amples of solutions which are isotonic
`with many mammalian cells are 0.9 per
`cent NaCl and 5.51 per cent dextrose.
`
`Certain chemicals and surface-active
`agents (2, 3) also cause hemolysis, but
`they do so by different mechanisms.
`Solutes such as urea, ammonium chlor(cid:173)
`ide, boric acid, and alcohol pass freely
`through the cell membrane and bring
`about hemolysis becau~e they do not
`provide any osmotic pressure to balance
`that of cell contents. Other substances
`of pharmaceutical interest which do not
`exert any osmotic pressure are succinic
`dinitrite, antipyrine, aminophylline, pro(cid:173)
`pylene glycol, and sodium phenobarbital
`(2). Surface-active agents such as poly(cid:173)
`sorbate 60 increase the permeability of
`the erythrocyte membrane
`to NaCl
`which normally does not pass through
`the membrane.
`
`FPD. The normal freezing point or
`melting point of a pure solvent is the
`temperature at which
`the solid and
`liquid phases coexist in equilibrium un(cid:173)
`der one atmospheric pressure. The
`vapor pressures of the liquid and the
`solid are equal at freezing point. If a
`is dissolved in the liquid the
`solute
`vapor pressure or the escaping tendency
`of the liquid sohent is lowered below
`that of
`the pure solvent. The
`tem(cid:173)
`perature must drop
`in order
`to re(cid:173)
`establish equilibrium between the liquid
`and the solid. In other words, the freez(cid:173)
`ing point of the pure solvent is lowered
`by dissolving a solute in it. The magni-
`
`Novo Nordisk Ex. 2039, P. 2
`Mylan Institutional v. Novo Nordisk
`IPR2020-00324
`
`

`

`Erythrocyte Fragility and lsotonicity Determination
`
`tude of the FPD is proportional to the
`concentration of the solute ( 4).
`The blood is an aqueous system con(cid:173)
`taining dissolved soh;tes and it would
`have a freezing point lower than that
`of pure water. An aqueous solution of
`the rnme
`NaCl, 0.90 per cent, has
`freezing point as that of blood. Since
`water is the solvent in both the case;,
`the FPD of 0.90 per cent NaCl= FPD
`of blood. A solution in question is said
`to be isotonic if it has the same colli(cid:173)
`gative property (FPD or osmotic pres(cid:173)
`sure) as that of blood and if the ery(cid:173)
`throcyte membrane is impermeable to
`the dissolved solutes.
`
`Apparatus and Materials
`Needed for
`this experiment are a
`Beckmann
`cryoscopic
`apparatus,
`a
`cryoscopic thermometer (Heidenhain),
`a magnifying glass, a centrifuge, a
`colorimeter, a microscope, centrifuge
`tubes in rack, defibrinated or heparin(cid:173)
`ized blood 1
`( canine or bovine), pipets
`(10.0 ml. in 0.1 and 0.01), silver ni(cid:173)
`trate, sodium nitrate, sodium chloride
`solutions (0.20, 0.90, and 1.8 per cent),
`3.6 per cent urea, 0.80 per cent am(cid:173)
`monium chloride, and l.9 per cent boric
`acid.
`
`Experimental Procedures
`The experiment can be performed
`over a two-week period with groups of
`two students. If desired, it can be per(cid:173)
`formed
`in one laboratory period by
`omitting the part on "quantitative study
`of erythrocyte fragility." The latter pro-
`
`1coagulation of blood was prevented by the
`following two procedures. Bovine blood was
`obtained from a local slaughterhouse and
`was collected in a container with glass beads
`and agitated
`immediately. In some cases
`agitation with a brush was helpful in sep(cid:173)
`arating the fibrin. In the case of canine
`blood the container was premoistened with
`four to five drops of 5 per cent heparin solu(cid:173)
`tion. The osmotic effect due to the small
`amount of heparin would be negligible, and
`this procedure is preferred.
`
`in the physical
`
`cedure was followed
`pharmacy laboratory.
`Effect of suspending erythrocytes in
`different concentrations of NaCl solu(cid:173)
`tions. Erythrocytes are suspended in
`water and in hypotonic ( distilled water
`or 0.20 per cent NaCl), in isotonic
`(0.90 per cent NaCl), and in hypertonic
`( 1.8 per cent NaCl) solutions. The salt
`solutions are supplied in the laboratory.
`In each of the four labeled test tubes
`containing 5 ml. of each of the above
`NaCl solutions, 0.1 ml. of the given
`blood is pipetted. Each tube is sealed
`with parafilm 2 and inverted gently about
`three times to ensure complete mixing.
`The mixture is allowed to stand for 30
`minutes. The tubes are held against a
`white background ( filter paper), and
`the appearances of the contents are
`noted. Alternately, the tubes are centri(cid:173)
`fuged3 (in which case centrifuge tubes
`should be used) at ca. 1500 rpm for 10
`minutes and the appearance noted; the
`advantage of this procedure is that it
`hastens the rate of sedimentation. This
`alternate procedure was followed by the
`students in the medical school. Either
`procedure gave satisfactory results.
`Effect of urea, ammonium chloride,
`and surface-active agent on the erythro(cid:173)
`cytes. This experiment illustrates that,
`although certain substances (urea, am(cid:173)
`monium chloride, and surface-active
`agents) cause hemolysis, they do so by
`different mechanisms. Using the pro(cid:173)
`cedure described in the preceding sec(cid:173)
`tion, the erythrocytes are suspended in
`5 ml. each of the following solutions:
`0.80 per cent ammonium chloride, 1.8
`per cent urea, 2.5 ml. of 3.6 per cent
`urea + 2.5 ml. of 1.8 per cent sodium
`chloride, and 5 ml. of 0.90 per cent
`sodium chloride + one drop of 10 per
`cent polysorbate 60. It should be noted
`that the above concentrations of am-
`
`2Parafilm, available from supply houses
`:JThe instructor or technician arranged for
`this.
`
`3
`
`l
`
`Novo Nordisk Ex. 2039, P. 3
`Mylan Institutional v. Novo Nordisk
`IPR2020-00324
`
`

`

`-
`
`-
`
`-
`
`-1
`
`American Journal of Pharmaceutical Education
`
`monium chloride (0.80 per cent) and
`urea ( 1.8 per cent) in the final solu(cid:173)
`tions are iso-osmotic with respect to red
`cells.
`
`Quantitative study of red cell fragility.
`This part describes, in a quantitative
`manner, osmotic hemolysis of the red
`cells in sodium chloride solution of vary(cid:173)
`ing concentrations.
`Ten milliliters of a series of the fol(cid:173)
`lowing concentrations of sodium chlor(cid:173)
`ide are prepared in eight test tubes by
`mixing appropriate amounts of 0.90 per
`cent sodium chloride solution and dis(cid:173)
`tilled water: 0.18, 0.36, 0.45, 0.54,
`0.63, 0.72, and 0.90 per cent. To each
`of these tubes is added (by means of
`a pipet) 0.05 ml. of the blood which
`has been thoroughly mixed ( the red
`cells sediment rapidly, and if the sample
`is not mixed different amounts of red
`cells may be added in each case). The
`tubes are now centrifuged at ca. 1500
`rpm for 10 minutes. By this procedure
`whole red cells and fragments are sedi(cid:173)
`mented. The clear supernatant solution
`is decanted into a cuvette and its optical
`density is measured on a spectrophoto(cid:173)
`meter (Spectronic 20) 4 • The first tube
`containing O per cent NaCl ( distilled
`water) is included as a reference tube,
`and the hemolysis of the red cells in
`this tube is taken as complete or 100 per
`cent for the purpose of calculations.
`Treatment of data. From the optical
`density reading of the first tube showing
`complete hemolysis, the magnitude of
`hemolysis for each of the other tubes is
`given as a simple proportion-e.g., if
`the first tube gives an optical density
`value of 0.600, then a tube giving a
`value of 0.300 yields 0.600/0.300 X
`100 = 50 per cent hemolysis.
`4The instruction sheets covering the principle
`and operation of the
`instrument together
`with its labelled diagram were given to the
`students.
`
`4
`
`A plot is prepared showing per cent
`hemolysis in increasing order along the
`ordinate and sodium chloride solution in
`order of decreasing strength along the
`abscissa. The points are connected in
`a continuous curve. The shape of the
`curve would be expected to be sigmoid
`in character, i.e., convex toward the base
`at lower salt concentrations and convex
`upward as hemolysis nears completion.
`Freezing point determination. The
`is
`Beckmann cryoscopic apparatusG
`portrayed in Fig. 1. In order to reduce
`the rate of cooling, the inner tube, con(cid:173)
`taining the solution, the stirrer, and the
`thermometer 6 , is partially insulated by
`being suspended in a larger test tube
`with an air space in between. The ice(cid:173)
`salt bath temperature should be about
`_50,
`
`STIRRER [stainless
`stee! wire)
`
`OUTER STIRRER
`
`RUBBER STOPPERS
`
`AIR JACKET
`
`Fig. l. The Beckmann cryoscopic apparatus
`
`~•The apparatus shown is of commercial design
`and is ob'.ainable from major supply houses.
`nThe Heidenhain thermometer, with an op(cid:173)
`erating temperature range of + l O to -5 °, is
`very suitable. It has an advantage over the
`Beckmann thermometer in that it is compar(cid:173)
`atively easy to set.
`
`Novo Nordisk Ex. 2039, P. 4
`Mylan Institutional v. Novo Nordisk
`IPR2020-00324
`
`

`

`Erythrocyte Fragility and Jsotonicity Determination
`
`About 20 ml. of the liquid under
`study is pipetted into the inner tube. The
`thermometer and the stirrer' are inserted
`with the thermometer carefully mounted
`in such a way that the bulb is about
`halfway between the bottom of the test
`tube and the upper surface of the liquid
`and concentric with the tube so that the
`stirrer can easily pass around it. If the
`thermometer is too close to the bottom
`a bridge of frozen solvent can easily
`form which will conduct heat away from
`the thermometer and result in low read(cid:173)
`ings.
`
`he motion of the stirrer should carry
`
`it from the bottom of the tube up to
`near the surface of the liquid; before
`starting the experiment, it is well to ob(cid:173)
`serve carefully how high the stirrer can
`be raised without too frequent splashing.
`The
`stirring
`should be continuous
`throughout the run and should be at the
`rate of about one stroke per second.
`The ice-salt bath should be stirred a few
`times per minute.
`
`The test tube containing the liquid,
`stopper, thermometer, and stirrer is held
`in a beaker of ice-salt mixture, and the
`liquid is stirred until it visibly starts to
`freeze. The outside of the tube is wiped
`dry and warmed (with stirring) care(cid:173)
`fully with the hand to at least 1 ° above
`the freezing point. Then the tube is
`placed in the assembled apparatus, and
`temperature readings are taken every
`20 ( or 30) seconds with the aid of a
`magnifying glass. The thermometer is
`tapped gently before a reading is taken
`to prevent sticking of the mercury in
`the very fine capillary, and the tem(cid:173)
`perature is estimated in tenths of the
`smallest scale division. Once freezing
`
`7A coiled multiloop stirrer (designed by Wal-
`ter S. Chen and easily prepared from a
`stainless steel wire by wrapping an end of
`the wire around glass tubing) is very effici(cid:173)
`ent and stays in place around the thermome(cid:173)
`ter during stirring.
`
`has occurred, the readings are taken
`for ca. 4-5 minutes; the temperature
`should remain fairly constant during
`that time. Supercooling will probably be
`experienced. A constant
`temperature
`shows that freezing is taking place.
`the
`Using
`the method described,
`freezing points of the following liquids
`are determined: 1) pure distilled water,
`2) 0.9 per cent NaCl, and 3) bovine
`blood or a prescription of 0.5 per cent
`silver nitrate ophthalmic solution ren(cid:173)
`dered isotonic with NaNO3 •
`
`Results and Discussion
`The summary of the results outlined
`is based on the data reported by the
`pharmacy and medical students.
`When
`the erythrocytes were sus(cid:173)
`pended in 0.20 per cent NaCl, hemo(cid:173)
`lysis occurred which was characterized
`by a clear pink solution, the cells having
`burst and released
`the hemoglobin.
`When they were suspended in isotonic
`(0.90 per cent) NaCl and hypertonic
`(1.8 per cent) NaCl, there was an ab(cid:173)
`sence of hemolysis marked by the sedi(cid:173)
`mentation of the cells with a clear zone.
`Microscopic observations showed that
`the red cells retained their normal shape
`in isotonic solution while they were
`crenated in hypertonic solution.
`The suspension of red cells into am(cid:173)
`monium chloride and urea solutions,
`which were
`iso-osmotic with respect
`to the cells, produced hemolysis, indi(cid:173)
`cated by a clear pink coloration of these
`solutions. These solutes pass through the
`membrane of the erythrocytes; therefore,
`they do not contribute to the osmotic
`pressure. The cells in the tube contain(cid:173)
`ing 0.90 per cent NaCl and 1.8 per
`cent urea failed to cause hemolysis, il(cid:173)
`lustrating that urea played no part in
`hemolysis and that the urea solution
`behaved essentially
`like pure water.
`This mixture is then no different from
`0.90 per cent NaCl as far as the erythro(cid:173)
`cytes are concerned. Hemolysis was,
`
`5
`
`Novo Nordisk Ex. 2039, P. 5
`Mylan Institutional v. Novo Nordisk
`IPR2020-00324
`
`

`

`American Journal of Pharmaceutical Education
`
`however, noticed in the tube where the
`cells were suspended in 0.90 per cent
`NaCl
`to which polysorbate 60 was
`added. This
`is because
`the surface(cid:173)
`active agent increases the permeability
`of the erythrocyte membrane to NaCl.
`The student data on the magnitude of
`hemolysis at varying concentrations of
`the salt solutions are plotted in Fig. 2.
`The results gave a S-shaped curve with
`hemolysis appearing
`rather
`sharply.
`There was a range of solute concentra(cid:173)
`tion before hemolysis occurred, indicat(cid:173)
`ing a range of "toughness" of the red
`cell membrane. In certain clinical cases
`of hemolytic anemia ( 5), as depicted in
`Fig. 3, the range of toughness is reduced,
`and osmotic fragility tests will show that
`the erythrocytes of such patients will
`
`100
`
`80
`
`V)
`
`V) >(cid:173)_J
`0
`:E 60
`w
`:r:
`1-z w
`u 40
`0:: w
`a..
`
`20
`
`in concentrations of NaCl
`hemolyze
`which fail to cause rupture of normal
`corpuscles.
`
`PER CENT HEMOLYSIS
`
`• PAMILIAL HEMOLYTIC JAUNDICE
`.t. NORMAL
`• BENZOL POISONING
`♦ COOLEY'S ANEMIA
`
`lO0
`
`80
`
`60
`
`40
`
`20
`
`CONCN. OF SODIUM CHLORIDE ( Gm.I 100 ml,)
`
`Fig. 3. Per cent hemolysis plotted against the
`concentrations of sodium chloride [after Hun(cid:173)
`ter, F.T. (5)]
`
`Based on student group data, typical
`cooling curves of distilled water, bovine
`blood, and isotonic solutions are shown
`in Fig. 4. The dip below the freezing
`point is due to supercooling, which al(cid:173)
`most invariably occurs. In the present
`experiment, supercooling rarely exceeds
`,---.---,,-,,-,----,-17
`
`• DISTILLED WATER l
`
`& BOVINE BLOOD
`■ NaCl, 0.9 Pi:RCl:NT
`0 5 PERCENT•
`1.08 PFRCl:NT
`
`~ -0.20
`
`~ -0.40- -
`w
`"' ::> -0.60
`~
`! 1-
`
`UJ -0.80
`
`- 1.00
`
`0
`040
`080
`CONCN. OF SODIUM CHLORIDE
`(Gm./100 ml.)
`Fig. 2. Student data plotted as per cent hem(cid:173)
`olysis against the concentration of sodium
`chloride. Each point represents the average of
`10 group results.
`
`6
`
`t
`SUPERCOOLING
`
`- I 20
`
`-1.40
`
`Fig. 4. Typical cooling curves of distilled
`water, bovine blood, isotonic sodium chlo(cid:173)
`ride, and an isotonic ophthalmic prescription
`
`Novo Nordisk Ex. 2039, P. 6
`Mylan Institutional v. Novo Nordisk
`IPR2020-00324
`
`

`

`Erythrocyte Fragility and Isotonicity Determination
`
`about 2 ° and is best kept around 1 ° by
`effective stirring. The
`recommended
`procedure for estimating the true freez(cid:173)
`ing point of the solution ( the tempera(cid:173)
`ture at which
`freezing would have
`started in the absence of supercooling)
`is to extrapolate back that point of the
`curve which corresponds to freezing out
`of the solvent until the extrapolate in(cid:173)
`tersects the cooling curve of the liquid
`solution ( 4). To a good approximation,
`the extrapolation may be taken as a
`linear one.
`
`According to the results, the freezing
`point depressions for bovine blood, 0.90
`per cent NaCl, and the silver nitrate
`ophthalmic solution ( a typical prescrip(cid:173)
`tion rendered isotonic) are 0.53 °, 0.54 °,
`and 0.52 °. These values compare favor(cid:173)
`ably with the reported value (3) of
`0.52 °. The results of the entire class
`showing the mean FPD value ±
`the
`standard deviation, and the total number
`of group data points, are summarized as
`follows: 0.90 per cent NaCl, 0.53 ° ±
`0.033 °, 24; bovine blood, 0.52 ° ±
`0.036°, 14; and the prescription, 0.53°
`± 0.041 °, 14, respectively. As is evi(cid:173)
`dent, both the above solutions have the
`same colligative property (FPD) as that
`of blood. Since the erythrocyte mem(cid:173)
`brane is impermeable to the solutes used,
`these solutions would be expected to
`
`have about the same osmotic pressure
`as that of blood, and they are isotonic."
`This experiment demonstrates the quan(cid:173)
`titative determination of isotonicity by
`the freezing point determination. D
`Note added in proof: An osmometer as uti(cid:173)
`lized by W. E. Hall (Am. J. Pharm. Educ., 34,
`204(1970)) would be satisfactory for FPD
`determinations. One of us experimented with
`an Osmette A (Precision Systems) for the
`determination of FPD of isotonic preparations
`and it gave excellent results. The assistance
`of G. J. Weber of Fisher Scientific Co. for a
`demonstration and loan of this apparatus for
`this purpose is appreciated.
`
`References
`( l) Meschia, G. and Setnikar, I., J.
`Gen. Physiol., 42, 429(1918).
`(2) Setnikar, I. and Temelcou, 0., J.
`Am. Pharm. Assoc., Sci. Ed., 48,
`628(1959).
`( 3) Sedam, R. L. and Osol, A., in
`Martin, E. W., Remington's Phar(cid:173)
`maceutical Sciences,
`13th
`ed.,
`Mack Publishing Company, Easton,
`Pennsylvania, 1965.
`( 4) Shoemaker, D. P. and Garland,
`C. W., Experiments in Physical
`Chemistry, McGraw Hill Book
`Company, Inc., New York, 1967,
`pp. 132-140.
`( 5) Hunter, F. T., J. Clin. Invest., 19,
`691 (1940).
`
`7
`
`Novo Nordisk Ex. 2039, P. 7
`Mylan Institutional v. Novo Nordisk
`IPR2020-00324
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket